Botulinum toxin in the management of chronic migraine: clinical evidence and experience.

about

Onabotulinum toxin A in the treatment of chronic migraine: patient selection and special considerations.Current Prophylactic Medications for Migraine and Their Potential Mechanisms of Action.Association between Cervical Spondylosis and Migraine: A Nationwide Retrospective Cohort Study.

P2860

Q42370565-0A733D06-C74C-440E-87E6-BA3C65A2DF62 Q53407201-A1755A59-D970-4EC5-B14A-6E60BAA1689D Q54989050-9FB8AF53-60CD-4F6B-B9A4-34FBF2A606FE

P2860

Botulinum toxin in the management of chronic migraine: clinical evidence and experience.

Item

http://www.wikidata.org/entity/Q37722781

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Botulinum toxin in the management of chronic migraine: clinical evidence and experience.

@en

Botulinum toxin in the management of chronic migraine: clinical evidence and experience.

@nl

type

Item

label

Botulinum toxin in the management of chronic migraine: clinical evidence and experience.

@en

Botulinum toxin in the management of chronic migraine: clinical evidence and experience.

@nl

prefLabel

Botulinum toxin in the management of chronic migraine: clinical evidence and experience.

@en

Botulinum toxin in the management of chronic migraine: clinical evidence and experience.

@nl

P1476

Botulinum toxin in the management of chronic migraine: clinical evidence and experience.

@en

P2093

Claus M Escher

http://www.w3.org/2001/XMLSchema#string

Dirk Dressler

http://www.w3.org/2001/XMLSchema#string

Katja Kollewe

http://www.w3.org/2001/XMLSchema#string

Lejla Paracka

http://www.w3.org/2001/XMLSchema#string

P2860

The effect of sodium valproate on chronic daily headache and its subgroups

Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy

The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves

The International Classification of Headache Disorders, 3rd edition (beta version)

Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache

The International Classification of Headache Disorders: 2nd edition

Prospective analysis of the use of OnabotulinumtoxinA (BOTOX) in the treatment of chronic migraine; real-life data in 254 patients from Hull, U.K.

OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program.

Botulinum toxin type A (BOTOX) for treatment of migraine headaches: an open-label study.

Botulinum toxin A for chronic daily headache: a randomized, placebo-controlled, parallel design study.

P304

127-135

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1756285616677005

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28382110

http://www.w3.org/2001/XMLSchema#string

P921

migraine disorder

P932

5367647

http://www.w3.org/2001/XMLSchema#string

Botulinum toxin in the management of chronic migraine: clinical evidence and experience.

about

P2860

P2860

Botulinum toxin in the management of chronic migraine: clinical evidence and experience.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932